The early diagnosis of phaeochromocytoma by measurement of catecholamines or their metabolites is important, since it brings the prospect of permanent cure to a small but significant proportion of the hypertensive population. The development of sensitive and specific methods for the analysis of catecholamines has led to the increased use of such measurements in the biochemical diagnosis and localisation of this rare tumour.
References
1.
LabbeMTinelJDoumerA. Crises solaires et hypertension paroxystique en rapport avec une tumeur surrénale. Bulletin et Mémoires de la Société Médical des Hopitaux de Paris1922; 46: 982–90.
2.
MayoC. Paroxysmal hypertension with tumor of retroperitoneal nerve. J Am Med Ass1927; 139: 1047–50.
3.
RuthvenCRJSandlerM. Neurogenic amines and secreting tumours. In: BrownSSMitchellFLYoungDS, eds. Chemical diagnosis of disease. Amsterdam: Elsevier/North Holland Biomedical Press, 1979; 1217–91.
4.
HermannHMornexR. Human tumours secreting catecholamines. Oxford: Pergamon Press, 1954.
5.
TishermanSEGreggFJDanowskiTS. Familial pheochromocytoma. J Am Med Ass1962; 182: 152–6.
6.
SippleJH. The association of phaeochromocytoma with carcinoma of the thyroid gland. Am J Med1961; 31: 163–6.
7.
CouplandRE. The chromaffin system. In: UsdinESnyderSH, eds. Handbook of experimental pharmacology. Volume 33, Catecholamines. Berlin: Springer-Verlag, 1972; 16–45.
KhanOWilliamsGChisholmGDPhaeochromocytomas of the bladder. J Roy Soc Med1982; 75: 17–20.
12.
GuptaKK. Phaeochromocytoma and myocardial infarction. Lancet1975; i: 281–2(L).
13.
BlaschkoH. The specific action of L-dopa decarboxylase. J Physiol1939; 96: 50P–51P.
14.
NagatsuTLevittMUdenfriendS. Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J Biol Chem1964; 239: 2910–7.
15.
KopinIJGordanEK. Metabolism of administered and drug released norepinephrine-7-H3 in the rat. J Pharmacol Exp Ther1963; 140: 207–16.
16.
AxelrodJ. O-methylation of epinephrine and other catechols in vitro and in vivo. Science1957; 126: 400–1.
17.
AxelrodJSenohSWitkopB. O-methylation of catecholamines in vivo. J Biol Chem1958; 233: 697–701.
18.
JohnstonJP. Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol1968; 17: 1285–97.
19.
CroutJRPisanoJJSjoerdsmaA. Urinary excretion of catecholamines and their metabolites in phaeochromocytoma. Am Heart J1961; 61: 375–81.
20.
GitlowSEMendlowitzMKrukEDiagnosis of phaeochromocytoma by assay of catecholamine metabolites. Circulation Res1961; 9: 746–53.
21.
EnglemanK. Phaeochromocytoma. Clinics in Endocrinology and Metabolism1977; 6: 769–97.
22.
PlouinPFDuclosJMMenardJBiochemical tests for diagnosis of phaeochromocytoma: Urinary versus plasma determinations. Br Med J1981; 282: 853–4.
23.
BrownMJDolleryCT. Once in a lifetime—phaeochromocytoma. Update1981; 23: 1237–43.
24.
CardonPVGuggenheimFG. Effects of large variations in diet on free catecholamines and their metabolites in urine. J Psychiat Res1970; 7: 263–73.
25.
MangerWMFlockEVBerksonJChemical quantitation of epinephrine and norepinephrine in thirteen patients with pheochromocytoma. Circulation1956; 10: 541–52.
BrownMJAllisonDADolleryCT. Unique role of plasma adrenaline measurements in the diagnosis of small phaeochromocytomas. Europ J Clin Invest1980; 10: abstract 28.
29.
CryerPE. Pheochromocytoma and autonomic dysfunction. Arch Intern Med1977; 137: 783–7.
30.
GangulyAHenryDPYuneHY. Diagnosis and localisation of pheochromocytoma: Detection by measurement of urinary norepinephrine excretion during sleep, plasma norepinephrine concentration and computerized axial tomography (CT-Scan). Am J Med1979; 67: 21–6.
31.
FeldmanJMBlalockJAFarrellREPlasma norepinephrine response to standing in patients with pheochromocytoma or medullary carcinoma of the thyroid. Arch Intern Med1979; 139: 81–5.
32.
BravoELTaraziRCGiffordRWCirculating and urinary catecholamines in pheochromocytoma: Diagnostic and pathophysiologic implications. New Engl J Med1979; 301: 682–6.
33.
Von EulerUSStromG. Present status of diagnosis and treatment of pheochromocytoma. Circulation1957; 15: 5–13.
34.
CouplandRE. The natural history of the chromaffin cell. London: Longmans Grenn. 1965.
35.
RobinsonRSmithPWhittakerSRF. Secretion of catecholamines in malignant phaeochromocytoma. Br Med J1964; i: 1422–3.
36.
GitlowSEBertaniLMGreenwoodSMBenign pheochromocytoma associated with elevated excretion of homovanillic acid. J Pediat1972; 81: 1112–6.
37.
SerranoPAChavez-LaraBSanchez-TorresG. Dopamine excretion in bengin pheochromocytoma. In: Catecholamines: Basic and Clinical Frontiers, 4th International Catecholamine Symposium 1979: UsdinEKopinIJBarchasJ, eds. New York: Pergamon Press, 1979; 1479–81.
38.
FreirDTHarrisTS. Rigorous biochemical criteria for the diagnosis of phaeochromocytoma. J Surg Res1973; 14: 177–80.
39.
YoungDSPestanerLCGibbermanV. Effects of drugs on clinical laboratory tests. Clin Chem1975; 21: 1D–432D.
40.
StoneCAPorterCC. Methyldopa and adrenergic nerve function. Pharmacol Rev1966; 18: 569–75.
41.
StottAWRobinsonR. The effect of alpha methyldopa on excretion of noradrenaline metabolites. J Pharm Pharmacol1967; 19: 690–3.
42.
HarrisDRichardsDA. Labetalol and urinary catecholamines. Br Med J1977; 4: 1673.
43.
ChapmanBPVeitchAGShepherdB. Labetalol and urinary catecholamines. Br Med J1978; 1: 364.
44.
HamiltonCAJonesDHDargieHJDoes labetalol increase excretion of urinary catecholamines?Br Med J1978; 2: 800.
45.
CarlesenJETrap-JensenJSvendsenTLEffect of labetalol on plasma catecholamines at rest and during increased sympathetic activity. Postgrad Med J1980; 56 (Suppl 2): 43–8.
46.
DescovitchGCMontalbettiNKuhlJFWAge and catecholamine rhythms. Chronobiology1974; 1: 163–71.
47.
BrownMJDolleryCT. A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma DOPA may be the precursor of urine free dopamine. Br J Clin Pharmacol1981; 1: 79–83.
48.
BrownMJAllisonDJ. Renal conversion of plasma DOPA to urine dopamine. Br J Clin Pharmacol1981; 12: 251–3.
49.
PisanoJJCroutJRAbrahamD. Determination of 3-methyoxy-4-hydroxymandelic acid in urine. Clin Chim Acta1962; 7: 285–91.
50.
PisanoJJ. A simple analysis for normetanephrine and metanephrine in urine. Clin Chim Acta1960; 5: 406–14.
51.
PisanoJJ. Assay of catecholamine metabolites based on vanillin formation. In: Methods in investigative and diagnostic endocrinology 1, BersonSARallJEKopinIJ, eds. New York: American Elsevier. 1972; 474–88.
52.
GitlowSEOrnsteinLMendlowitzMA simple colorimetric urine test for phaeochromocytoma. Am J Med1960; 28: 921–6.
53.
VauquelinGVerheydonREbingerGDiazotization of catecholamines and their analogues and metabolites for urinary screening tests: Chemical aspects. Clin Chem1976; 22: 1955–61.
54.
KnightJAFronkSHaymondRE. Chemical basis and specificity of chemical screening tests for urinary vanilmandelic acid. Clin Chem1975; 21: 130–3.
55.
ChouDTsuruMHoltzmanJLInterference by the 4-hydroxylated metabolite of propranolol with determination of metanephrines by the Pisano method. Clin Chem1980; 26: 776–7.
56.
MandiedoGSmurawaB. Interference by triamterene with assay for metanephrine. Clin Chem1980; 26: 782L.
57.
Van De CalseydeJFScholtisRJHSchmidtNAGas chromatography in the estimation of urinary metanephrines and VMA. Clin Chim Acta1971; 32: 361–6.
58.
NelsonLMBubbFALaxPMAn improved method for the differential assay of 3-O-methylated catecholamines in human urine using ion-pair extraction and gas chromatography electron capture detection. Clin Chim Acta1979; 92: 235–40.
59.
AndersonGMYoungJG. Minireview: Applications of liquid chromatographic-fluorimetric systems in neurochemistry. Life Sciences1981; 28: 507–17.
60.
KissingerPTRefshaugeCDreilingRAn electrochemical detector for liquid chromatography with picogram sensitivity. Analytical Letters1973; 6: 465–77.
61.
YamadaKKayamaEAizawaYDetermination of vanillylmandelic acid in urine by pre-column dansylation using micro high performance liquid chromatography with fluorescence detection. J Chromatogr1981; 223: 176–8.
62.
MorriseyJLShihabiZK. Assay of 4 hydroxy 3 methoxy mandelic (vanillylmandelic) acid by liquid chromatography with electrochemical detection. Clin Chem1979; 25: 2043–5.
63.
ShoupREKissingerPT. Determination of urinary normetanephrine, metanephrine and 3 methoxytyramine by liquid chromatography with amperometric detection. Clin Chem1977; 23: 1268–74.
64.
Bertani-DziedzicLMKrstuloicAMDziedzicSWAnalysis of urinary metanephrines by reverse phase high performance liquid chromatography and electrochemical detection. Clin Chim Acta1981; 110: 1–8.
65.
NelsonLMCarruthersM. Semi-automated fluorimetric method for the estimation of urinary catecholamines using high performance liquid chromatography. J Chromatogr1980; 183: 295–302.
66.
JackmanGP. Differential assay for urinary catecholamines by use of liquid chromatography with fluorescence detection. Clin Chem1981; 27: 1202–4.
KissingerPTRigginRMAlcornRLEstimation of catecholamines in urine by reverse phase liquid chromatography with electrochemical detection. Biochem Med1975; 13: 299–306.
69.
RigginRMKissingerPT. Determination of catecholamines in urine by reverse phase liquid chromatography with electrochemical detection. Analyt Chem1977; 49: 2109–11.
70.
MoyerTPJiangN-STyceGMAnalysis for urinary catecholamines by liquid chromatography with amperometric detection: Methodology and clinical interpretation of results. Clin Chem1979; 25: 256–63.
71.
SoldinSJLamGPollardAHigh performance liquid chromatographic analysis of urinary catecholamines employing amperometric detection: Reference values and use in laboratory diagnosis of neural crest tumours. Clin Biochem1980; 13: 285–91.
72.
Da PradaMZurcherG. Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sciences1976; 19: 1161–74.
73.
PeulerJDJohnsonGA. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sciences1977; 21: 626–36.
74.
BrownMJJennerDA. Novel double isotope technique for enzymatic assay of catecholamines, permitting high precision, sensitivity and plasma sample capacity. Clin Sci1981; 61: 591–8.
75.
ThiedeH-MKehrW. Conjoint radioenzymatic measurement of catecholamines, their catechol metabolites and DOPA in biological samples. Naunyn Schmiedebergs Archives of Pharmacology1981; 318: 119–28.
76.
YuiYFujitaTYamamotoTLiquid-chromatographic determination of norepinephrine and epinephrine in human plasma. Clin Chem1980; 26: 194–6.
77.
YamatodaniAWadaH. Automated analysis for plasma epinephrine and norepinephrine by liquid chromatography, including sample clean up procedure. Clin Chem1981; 27: 1983–7.
78.
HallmanHFarneboLOHambergerBA sensitive method for the determination of plasma catecholamines using liquid chromatography with electrochemical detection. Life Sciences1978; 23: 256–63.
79.
HjemdahlPDaleskogMKahanT. Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: Comparison with a radioenzymatic method. Life Sciences1979; 25: 131–8.
80.
GoldsteinDSFeuersteinGZIzzoJLJrValidity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sciences1981; 28: 467–75.
81.
BrownMJJennerDA. Simultaneous determination of endogenous catecholamines, alpha methyldopa and alpha methylnoradrenaline in plasma using HPLC with electrochemical detection. Br J Clin Pharmacol1981; 11: 435P.
82.
DavisGCKissingerPTShoupRE. Strategies for determination of serum or plasma norepinephrine by reverse phase liquid chromatography. Analyt Chem1981; 53: 156–9.
83.
WatsonE. Liquid chromatography with electrochemical detection for plasma norepinephrine and epinephrine. Life Sciences1981; 28: 493–7.
84.
CausonRCCarruthersMERodnightR. Assay of plasma catecholamines by liquid chromatography with electrochemical detection. Analyt Biochem1981; 116: 223–6.
85.
MichaudRLBannonMJRothRH. The use of C8-octyl columns for the analysis of catecholamines by ion-pair reversed phase liquid chromatography with amperometric detection. J Chromatogr1981; 225: 333–45.
86.
LevinBERappaportMNatelsonBH. Ultradian variations of plasma noradrenaline in humans. Life Sciences1979; 25: 621–8.
87.
BrownMJLewisPJDolleryCT. Diagnosis of small phaeochromocytomas. Lancet1980; 1: 1185–6.
88.
BrownMJAllisonDJJennerDAIncreased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma adrenaline estimations and a pentolinium-suppression test. Lancet1981; 1: 174–7.
89.
ShepsSGTyceGMHockEVCurrent experience in the diagnosis of phaeochromocytoma. Circulation1966; 34: 473–82.
90.
MetzSAHalterJBPorteDJrSuppression of plasma catecholamines and flushing by clonidine in man. J Clin Endocrinol Metab1978; 46: 83–90.
91.
MetzSAHalterJB. Effects of clonidine on hormone and substrate responses to hypoglycaemia. Clin Pharmacol Ther1980; 28: 441–8.
92.
BravoELTaraziRCFouadFMClonidine-suppression test: A useful aid in the diagnosis of phaeochromocytoma. New Engl J Med1981; 305: 623–6.
93.
BrownMJLewisPJ. Clonidine-suppression test for the diagnosis of phaeochromocytoma. New Engl J Med1982; 306: 49L.
94.
HalterJBBeardJCPfeiferMAClonidine-suppression test for diagnosis of phaeochromocytoma. New Engl J Med1982; 306: 49–50L.
95.
MurphyMBBrownMJCausonRThe effects of pentolinium on plasma catecholamines in hypertensives and normal controls. Br J Clin Pharmacol1982; 13: 608P.
96.
JonesHDAllisonDJHamiltonCASelective venous sampling in the diagnosis and localization of phaeochromocytoma. Clin Endocrinol1979; 10: 179–86.
97.
BrownMJJennerDAAllisonDJVariations in individual organ release of noradrenaline measured by an improved radioenzymatic technique; limitations of peripheral venous measurements in the assessment of sympathetic nervous activity. Clin Sci1981; 61: 585–90.
98.
StewartBHBrownELHaagaJLocalization of phaeochromocytoma by computed tomography. New Engl J Med1978; 299: 460–1.
99.
SissonJCFragerMSValkTWScintographic localization of phaeochromocytoma. New Engl J Med1981; 305: 12–17.
100.
RobinsonR. Tumours that secrete catecholamines. Chichester: Wiley, 1980; 43.
101.
YamamotoTJoTIshibashiT. Phaeochromocytoma with nocturnal elevation in blood pressure. Postgrad Med J1978; 54: 40–3.
102.
HustonJRStewartWRC. Hemorrhagic pheochromocytoma with shock and abdominal pain. Am J Med1965; 39: 502–4.
103.
TimmermansPBMWMWilffertBVan ZwietenP. Extrasynaptic location of vascular α2 and β2-adrenoceptors in the normotensive rat. Br J Pharmacol1982; 75: 72P.
104.
EnglemanKHorwitzDJequierEBiochemical and pharmacologic effects of alpha methyl tyrosine in man. J Clin Invest1968; 47: 577–94.
105.
EngelmanKSjoedsmaA. Chronic medical therapy for phaeochromocytoma: A report of 4 cases. Ann Intern Med1964; 61: 229–41.
